Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
- DOI
- 10.1097/ju.0000000000001199
- Published
- 2020-12
- Container
- Journal of Urology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/ju.0000000000001199,
title = {Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors},
author = {Guru Sonpavde and Juliane Manitz and Chen Gao and Darren Tayama and Constanze Kaiser and Daniel Hennessy and Doris Makari and Ashok Gupta and Shaad Essa Abdullah and Guenter Niegisch and Jonathan E. Rosenberg and Dean F. Bajorin and Petros Grivas and Andrea B. Apolo and Robert Dreicer and Noah M. Hahn and Matthew D. Galsky and Andrea Necchi and Sandy Srinivas and Thomas Powles and Toni K. Choueiri and Gregory R. Pond},
year = {2020},
journal = {Journal of Urology},
doi = {10.1097/ju.0000000000001199},
url = {https://doi.org/10.1097/ju.0000000000001199}
}RIS
TY - JOUR TI - Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors AU - Guru Sonpavde AU - Juliane Manitz AU - Chen Gao AU - Darren Tayama AU - Constanze Kaiser AU - Daniel Hennessy AU - Doris Makari AU - Ashok Gupta AU - Shaad Essa Abdullah AU - Guenter Niegisch AU - Jonathan E. Rosenberg AU - Dean F. Bajorin AU - Petros Grivas AU - Andrea B. Apolo AU - Robert Dreicer AU - Noah M. Hahn AU - Matthew D. Galsky AU - Andrea Necchi AU - Sandy Srinivas AU - Thomas Powles AU - Toni K. Choueiri AU - Gregory R. Pond PY - 2020 JO - Journal of Urology DO - 10.1097/ju.0000000000001199 UR - https://doi.org/10.1097/ju.0000000000001199 ER -
APA
Sonpavde, G., Manitz, J., Gao, C., Tayama, D., Kaiser, C., Hennessy, D., Makari, D., Gupta, A., Abdullah, S. E., Niegisch, G., Rosenberg, J. E., Bajorin, D. F., Grivas, P., Apolo, A. B., Dreicer, R., Hahn, N. M., Galsky, M. D., Necchi, A., Srinivas, S., Powles, T., Choueiri, T. K., & Pond, G. R. (2020). Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors. Journal of Urology. https://doi.org/10.1097/ju.0000000000001199
Source records
- crossref · retrieved 2026-09-26T16:52:56.949Z